|
|
FDA Safety Changes: Comtan, Stalevo, Tasmar, Symmetrel, Xenical, Casodex
|
| Link ID |
15272 |
| Title |
FDA Safety Changes: Comtan, Stalevo, Tasmar, Symmetrel, Xenical, Casodex |
| Url |
http://www.medscape.com/viewarticle/701711?src=rss |
| Description |
The FDA has approved safety labeling revisions for entacapone tablets, levodopa/carbidopa/entacapone tablets, tolcapone tablets, amantadine HCl syrup and tablets, orlistat, and bicalutamide. Medscape Medical News |
| Category |
Articles > Diabetes and Endocrinology |
| Keywords |
|
| Date |
Apr 23, 2009 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Diabetes and Endocrinology |
| 2. |
U.S. Medicare May Broaden Obesity Surgery Payment
|
|
|
The U.S. Medicare program may expand reimbursement for bariatric surgery for the obese, in light of a study that found the treatment can help reverse diabetes, the agency said on Monday. Reuters Health Information
|
|
|